Topic Highlight
Copyright ©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Jan 7, 2014; 20(1): 45-52
Published online Jan 7, 2014. doi: 10.3748/wjg.v20.i1.45
Current issues in pediatric inflammatory bowel disease-associated arthropathies
Sabrina Cardile, Claudio Romano
Sabrina Cardile, Claudio Romano, Department of Pediatrics, University of Messina, 98125 Messina, Italy
Author contributions: The authors have equally contributed to the conception and design of the study, with final approval of the version for the publication.
Correspondence to: Claudio Romano, MD, Department of Pediatrics, University of Messina, Via Consolare Valeria, 98125 Messina, Italy. romanoc@unime.it
Telephone: +39-90-2212918 Fax: +39-90-2213788
Received: September 25, 2013
Revised: October 17, 2013
Accepted: November 3, 2013
Published online: January 7, 2014
Abstract

Joint involvement is the most common extraintestinal manifestation in children with inflammatory bowel disease (IBD) and may involve 16%-33% of patients at diagnosis or during follow-up. It is possible to distinguish asymmetrical, transitory and migrating arthritis (pauciarticular and polyarticular) and spondyloarthropathy (SpA). Clinical manifestations can be variable, and peripheral arthritis often occurs before gastrointestinal symptoms develop. The inflammatory intestinal pattern is variable, ranging from sub-clinical inflammation conditions, classified as indeterminate colitis and nodular lymphoid hyperplasia of the ileum, to Crohn’s disease or ulcerative colitis. Unlike the axial form, there is an association between gut inflammation and evolution of recurrent peripheral articular disease that coincides with a flare-up of intestinal disease. This finding seems to confirm a key role of intestinal inflammation in the pathogenesis of SpA. An association between genetic background and human leukocyte antigen-B27 status is less common in pediatric than n adult populations. Seronegative sacroiliitis and SpA are the most frequent forms of arthropathy in children with IBD. In pediatric patients, a correct therapeutic approach relies on the use of nonsteroidal antiinflammatory drugs, local steroid injections, physiotherapy and anti-tumor necrosis factor therapy (infliximab). Early diagnosis of these manifestations reduces the risk of progression and complications, and as well as increasing the efficacy of the therapy.

Keywords: Inflammatory bowel disease, Spondyloarthropathy, Sacroiliitis, Infliximab, Extraintestinal manifestations

Core tip: Extraintestinal manifestations in pediatric patients with inflammatory bowel disease (IBD) are very common and are often underestimated, despite provoking a significant impairment of quality of life of patients. This review examines recent literature concerning joint involvement in the course of IBD, focusing on the most important aspects regarding classification of forms of arthropathy, pathogenesis and the essential elements for a correct diagnostic and therapeutic approach.